miR-30d Blocked Transforming Growth Factor β1-Induced Epithelial-Mesenchymal Transition by Targeting Snail in Ovarian

Zhongxue Ye1, Le Zhao, Jie Li

  • 1Centers for *Translational Medicine and †Laboratory Medicine, the First Affiliated Hospital, Xi'an Jiaotong University College of Medicine, Xi'an, Shaanxi, People's Republic of China.

Abstract

Insights

MicroRNA-30d (miR-30d) suppresses ovarian cancer progression by inhibiting epithelial-mesenchymal transition (EMT) and targeting Snail. This finding suggests miR-30d analogs could be potential ovarian cancer therapeutics.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Gene Regulation

Background:

  • MicroRNAs (miRs) regulate gene expression and their dysregulation is implicated in cancer.
  • Epithelial-mesenchymal transition (EMT) is a key process in cancer development and metastasis.
  • The role of miR-30d in transforming growth factor β1 (TGF-β1)-induced EMT in ovarian cancer requires further investigation.

Purpose of the Study:

  • To investigate the role of miR-30d in TGF-β1-induced EMT in ovarian cancer cells.
  • To identify the molecular mechanisms underlying miR-30d's function in ovarian cancer progression.

Main Methods:

  • TGF-β1 was used to induce EMT in ovarian cancer cell lines (SKOV3 and 3AO).
  • Quantitative real-time PCR and Western blot were used to assess gene and protein expression (E-cadherin, N-cadherin, vimentin, Snail).
  • Cell migration and invasion assays were performed, and luciferase assays verified direct targeting of Snail by miR-30d.

Main Results:

  • TGF-β1 induction led to down-regulation of miR-30b, miR-30c, and miR-30d in ovarian cancer cells.
  • Restoring miR-30d expression reversed EMT phenotypes, including morphological changes and altered molecular marker expression.
  • miR-30d directly targets and inhibits Snail expression, a key regulator of EMT.

Conclusions:

  • miR-30d acts as a tumor suppressor in ovarian cancer by inhibiting TGF-β1-induced EMT.
  • The mechanism involves the direct downregulation of Snail expression.
  • miR-30d analogs hold potential as therapeutic agents for ovarian cancer treatment.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K